Literature DB >> 8605631

X-ray structure of Streptococcus pneumoniae PBP2x, a primary penicillin target enzyme.

S Pares1, N Mouz, Y Pétillot, R Hakenbeck, O Dideberg.   

Abstract

All beta-lactam antibiotics exert their biological effects by interacting with a unique class of proteins, the penicillin-binding proteins (PBPs). These membrane proteins are involved in the biosynthesis of the murein or peptidoglycan, a mesh-like structure which completely surrounds the bacterial cell. Sequence similarities indicate that one domain of these proteins belongs to a large family of beta-lactam-recognizing proteins, which includes the active-site serine beta-lactamases. We here report the first three-dimensional crystal structure of a high molecular weight penicillin-binding protein, PBP2x of Streptococcus pneumoniae, at 3.5 A resolution. The molecule has three domains, the central domain being a transpeptidase, which is a suitable target for antibiotic development.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605631     DOI: 10.1038/nsb0396-284

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  67 in total

1.  Mutational analysis of the Streptococcus pneumoniae bimodular class A penicillin-binding proteins.

Authors:  J Paik; I Kern; R Lurz; R Hakenbeck
Journal:  J Bacteriol       Date:  1999-06       Impact factor: 3.490

2.  Construction of a full three-dimensional model of the transpeptidase domain of Streptococcus pneumoniae PBP2x starting from its Calpha-atom coordinates.

Authors:  P A van Hooft; H D Höltje
Journal:  J Comput Aided Mol Des       Date:  2000-11       Impact factor: 3.686

Review 3.  Lack of cell wall peptidoglycan versus penicillin sensitivity: new insights into the chlamydial anomaly.

Authors:  J M Ghuysen; C Goffin
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

4.  A 1.2-A snapshot of the final step of bacterial cell wall biosynthesis.

Authors:  W Lee; M A McDonough; L Kotra; Z H Li; N R Silvaggi; Y Takeda; J A Kelly; S Mobashery
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

5.  Functional characterization of penicillin-binding protein 1b from Streptococcus pneumoniae.

Authors:  Anne Marie Di Guilmi; Andréa Dessen; Otto Dideberg; Thierry Vernet
Journal:  J Bacteriol       Date:  2003-03       Impact factor: 3.490

Review 6.  Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent.

Authors:  Colette Goffin; Jean-Marie Ghuysen
Journal:  Microbiol Mol Biol Rev       Date:  2002-12       Impact factor: 11.056

7.  Diversity of substitutions within or adjacent to conserved amino acid motifs of penicillin-binding protein 2X in cephalosporin-resistant Streptococcus pneumoniae isolates.

Authors:  Y Asahi; Y Takeuchi; K Ubukata
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

8.  Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae.

Authors:  K Ubukata; Y Shibasaki; K Yamamoto; N Chiba; K Hasegawa; Y Takeuchi; K Sunakawa; M Inoue; M Konno
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

9.  Genetic analysis of the cell division protein FtsI (PBP3): amino acid substitutions that impair septal localization of FtsI and recruitment of FtsN.

Authors:  Mark C Wissel; David S Weiss
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

10.  Evidence from artificial septal targeting and site-directed mutagenesis that residues in the extracytoplasmic β domain of DivIB mediate its interaction with the divisomal transpeptidase PBP 2B.

Authors:  Susan L Rowland; Kimberly D Wadsworth; Scott A Robson; Carine Robichon; Jon Beckwith; Glenn F King
Journal:  J Bacteriol       Date:  2010-09-24       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.